Treatment patterns and outcomes of high-grade immune checkpoint inhibitor-related pneumonitis in an oncology hospitalist service

Purpose Immune checkpoint inhibitors (ICI) have become standard of care for some types of lung cancer. Along with expanding usage comes the emergence of immune-related adverse events (irAEs), including ICI-related pneumonitis (ICI-P). Treatment guidelines for managing irAEs have been developed; howe...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Supportive care in cancer 2024-03, Vol.32 (3), p.160-160, Article 160
Hauptverfasser:	Manzano, Joanna-Grace M., Sahar, Hadeel, Aldrich, Jeffrey, Lu, Maggie, Shoukier, Mahran, Peterson, Christine B., Dickson, Kodwo, Koom-Dadzie, Kwame, Kheder, Ed, Franco Vega, Maria C, Mohammed, Alyssa, Muthu, Mayoora, Simbaqueba, Cesar, Senechalle, Michelle Sibille, Brito-Dellan, Norman
Format:	Artikel
Sprache:	eng
Schlagworte:	Aftercare Clinical outcomes Hospitalists Humans Immune Checkpoint Inhibitors - adverse effects Lung cancer Lung Neoplasms - drug therapy Medicine Medicine & Public Health Mortality Nursing Nursing Research Oncology Pain Medicine Patient Discharge Patients Pneumonia - chemically induced Pulmonology Rehabilitation Medicine Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!